Pancreatic Neoplasms

Download PDF

Recent Publications on Pancreatic Neoplasms:
Nonmetastatic pancreatic cancer: many trials, little progress. Molecular analyses of neoplasms of the pancreas, coupled with careful...	9th July, 2008		J Clin Oncol. 2008 Jun 20;26(18):3100; author reply 3100-a-3101. DOI Direct Link
Erosive dermatitis and progressive neurological symptoms--quiz case. BACKGROUND: The optimal interval of imaging studies for surveillance of...	9th July, 2008	Dermatology Associates, Manitowoc, Wisconsin, USA.	Arch Dermatol. 2008 Jun;144(6):795-800. DOI Direct Link
A case of multiple hepatic metastases from pancreatic endocrine carcinoma. Molecular analyses of neoplasms of the pancreas, coupled with careful...	8th July, 2008	Hepatobiliary and Pancreatic Surgery Division, National Cancer Center	Jpn J Clin Oncol. 2008 Jun;38(6):455. DOI Direct Link
Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. BACKGROUND & AIMS: Although the cell of origin for pancreatic cancer...	8th July, 2008	Department of Surgery, The Sol Goldman Center for Pancreatic Cancer	Gastroenterology. 2008 Jun;134(7):2080-90. Epub 2008 Mar 5. DOI Direct Link
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. Pancreatobiliary cancers have among the highest mortality rates of any...	3rd July, 2008	Department of Pathology, Stanford University, Stanford, California, United	PLoS Genet. 2008 May 23;4(5):e1000081. DOI Direct Link
→View more research publications.

BioNews Results for Pancreatic Neoplasms:
Digestive Disease Week study examined ACR's guidelines for CT colonography interpretation	Genetic Engineering News:  Jul 11 2008 5:13AM Matching: pancreatic neoplasms

Pancreatic Neoplasms Clinical Trials:
Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	Pancreatic Cancer
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer	Drug/Agent Toxicity by Tissue/Organ;   Pancreatic Cancer
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer	Pancreatic Cancer
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	Pancreatic Cancer
Trial of Curcumin in Advanced Pancreatic Cancer	Pancreatic Neoplasms;   Adenocarcinoma
→View more trials.

Pancreatic Neoplasms Patents:
US Patent No.	Title
7381800	Antibodies to HBIMF63 polypeptide
6946134	Albumin fusion proteins
6926898	Albumin fusion proteins
6919433	Antibodies to protein HPMBQ91
6905688	Albumin fusion proteins
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Pancreatic Neoplasms scientists - we have details of around 3564 individuals working on Pancreatic Neoplasms .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.